Inflammatory pseudotumors (IPTs) of the lymph node and spleen are an uncommon, benign
cause of lymphadenopathy and/or splenomegaly that often bear striking clinicopathologic …

Approximately 50% of conventional inflammatory myofibroblastic tumors (IMTs) harbor ALK
gene rearrangement and overexpress ALK. Recently, gene fusions involving other kinases …

Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm of intermediate
biological potential, which may recur and rarely metastasize. Pathologic features do not …

Aims The aim of this study was to elucidate the pathological features of inflammatory
myofibroblastic tumour (IMT) with gene rearrangement other than ALK. Methods and results …

Inflammatory myofibroblastic tumor is a distinctive, rarely metastasizing mesenchymal
neoplasm composed of fascicles of spindle cells with a prominent inflammatory infiltrate …

In this report, we describe an inflammatory myofibroblastic tumor (IMT) of the urinary bladder
in a 46‐year‐old man. Tumor cells presented striking cytoplasmatic ALK immunopositivity …

Inflammatory myofibroblastic tumor (IMT) of the bladder is an uncommon myofibroblastic
spindle cell proliferation. Because of its cytologic features and infiltrative nature, it may be …

Purpose: The anaplastic lymphoma kinase (ALK) inhibitor crizotinib has been used in
patients with lung cancer or inflammatory myofibroblastic tumor (IMT), both types harboring …

Inflammatory myofibroblastic tumor (IMT) and low-grade myofibroblastic sarcoma (LGMS)
are intermediate-or low-grade malignant myofibroblastic neoplasms. In this study, the …

ALK-directed therapy has emerged as a highly effective treatment option for a subset of
patients with IMT and pulmonary adenocarcinoma. A number of additional malignancies …